Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1995;73(1):7–10.

Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer.

S J Winawer 1, D J St John 1, J H Bond 1, P Rozen 1, R W Burt 1, J D Waye 1, O Kronborg 1, M J O'Brien 1, D T Bishop 1, R C Kurtz 1, et al.
PMCID: PMC2486580  PMID: 7704928

Abstract

Recently published good quality data are the basis for this update. The newly reported studies include randomized trials, non-randomized cohort studies, and case-control studies; some of the data had mortality reduction as the endpoint. These guidelines, which were developed by the WHO Collaborating Center for the Prevention of Colorectal Cancer at Memorial Sloan-Kettering Cancer Center in conjunction with an International Advisory Committee, include primary prevention, screening of average-risk individuals, screening of individuals with heritable factors for colorectal cancer, surveillance of patients with colorectal polyps, and surveillance of patients with chronic ulcerative colitis. A list of papers reviewed for this update are cited, including recently published trials evaluating faecal occult-blood testing, case-control studies of sigmoidoscopy, the National Polyp study, and familial colon cancer studies. These guidelines will help inform patients and guide physicians in their approach to the prevention of colorectal cancer.

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin W. S., Morson B. C., Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992 Mar 5;326(10):658–662. doi: 10.1056/NEJM199203053261002. [DOI] [PubMed] [Google Scholar]
  2. Bond J. H. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology. Ann Intern Med. 1993 Oct 15;119(8):836–843. doi: 10.7326/0003-4819-119-8-199310150-00010. [DOI] [PubMed] [Google Scholar]
  3. Bonelli L., Martines H., Conio M., Bruzzi P., Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer. 1988 Apr 15;41(4):513–517. doi: 10.1002/ijc.2910410407. [DOI] [PubMed] [Google Scholar]
  4. Brown M. L. Screening for colorectal cancer. N Engl J Med. 1993 Oct 28;329(18):1352–1353. [PubMed] [Google Scholar]
  5. Burt R. W., Bishop D. T., Lynch H. T., Rozen P., Winawer S. J. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68(5):655–665. [PMC free article] [PubMed] [Google Scholar]
  6. Choi P. M., Nugent F. W., Schoetz D. J., Jr, Silverman M. L., Haggitt R. C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993 Aug;105(2):418–424. doi: 10.1016/0016-5085(93)90715-o. [DOI] [PubMed] [Google Scholar]
  7. Faivre J., Arveux P., Milan C., Durand G., Lamour J., Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev. 1991 Oct;1(1):49–55. [PubMed] [Google Scholar]
  8. Giovannucci E., Colditz G. A., Stampfer M. J., Hunter D., Rosner B. A., Willett W. C., Speizer F. E. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst. 1994 Feb 2;86(3):192–199. doi: 10.1093/jnci/86.3.192. [DOI] [PubMed] [Google Scholar]
  9. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Kearney J., Willett W. C. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst. 1994 Feb 2;86(3):183–191. doi: 10.1093/jnci/86.3.183. [DOI] [PubMed] [Google Scholar]
  10. Hardcastle J. D., Thomas W. M., Chamberlain J., Pye G., Sheffield J., James P. D., Balfour T. W., Amar S. S., Armitage N. C., Moss S. M. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989 May 27;1(8648):1160–1164. doi: 10.1016/s0140-6736(89)92750-5. [DOI] [PubMed] [Google Scholar]
  11. Jørgensen O. D., Kronborg O., Fenger C. The Funen Adenoma Follow-Up Study. Characteristics of patients and initial adenomas in relation to severe dysplasia. Scand J Gastroenterol. 1993 Mar;28(3):239–243. doi: 10.3109/00365529309096079. [DOI] [PubMed] [Google Scholar]
  12. Jørgensen O. D., Kronborg O., Fenger C. The Funen Adenoma Follow-up Study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol. 1993 Oct;28(10):869–874. doi: 10.3109/00365529309103127. [DOI] [PubMed] [Google Scholar]
  13. Kewenter J., Björk S., Haglind E., Smith L., Svanvik J., Ahrén C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988 Aug 1;62(3):645–651. doi: 10.1002/1097-0142(19880801)62:3<645::aid-cncr2820620333>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  14. Kronborg O., Fenger C., Worm J., Pedersen S. A., Hem J., Bertelsen K., Olsen J. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1992;27(1):47–52. doi: 10.3109/00365529209011166. [DOI] [PubMed] [Google Scholar]
  15. Lennard-Jones J. E., Melville D. M., Morson B. C., Ritchie J. K., Williams C. B. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990 Jul;31(7):800–806. doi: 10.1136/gut.31.7.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Levin B., Lennard-Jones J., Riddell R. H., Sachar D., Winawer S. J. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1991;69(1):121–126. [PMC free article] [PubMed] [Google Scholar]
  17. Levin B., Murphy G. P. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992 Sep-Oct;42(5):296–299. doi: 10.3322/canjclin.42.5.296. [DOI] [PubMed] [Google Scholar]
  18. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  19. Newcomb P. A., Norfleet R. G., Storer B. E., Surawicz T. S., Marcus P. M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992 Oct 21;84(20):1572–1575. doi: 10.1093/jnci/84.20.1572. [DOI] [PubMed] [Google Scholar]
  20. Ponz de Leon M., Antonioli A., Ascari A., Zanghieri G., Sacchetti C. Incidence and familial occurrence of colorectal cancer and polyps in a health-care district of northern Italy. Cancer. 1987 Dec 1;60(11):2848–2859. doi: 10.1002/1097-0142(19871201)60:11<2848::aid-cncr2820601141>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  21. Selby J. V., Friedman G. D., Quesenberry C. P., Jr, Weiss N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992 Mar 5;326(10):653–657. doi: 10.1056/NEJM199203053261001. [DOI] [PubMed] [Google Scholar]
  22. St John D. J., McDermott F. T., Hopper J. L., Debney E. A., Johnson W. R., Hughes E. S. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993 May 15;118(10):785–790. doi: 10.7326/0003-4819-118-10-199305150-00005. [DOI] [PubMed] [Google Scholar]
  23. Wahrendorf J., Robra B. P., Wiebelt H., Oberhausen R., Weiland M., Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev. 1993 May;2(3):221–227. [PubMed] [Google Scholar]
  24. Winawer S. J., Flehinger B. J., Schottenfeld D., Miller D. G. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993 Aug 18;85(16):1311–1318. doi: 10.1093/jnci/85.16.1311. [DOI] [PubMed] [Google Scholar]
  25. Winawer S. J., O'Brien M. J., Waye J. D., Kronborg O., Bond J., Frühmorgen P., Sobin L. H., Burt R., Zauber A., Morson B. Risk and surveillance of individuals with colorectal polyps. Who Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68(6):789–795. [PMC free article] [PubMed] [Google Scholar]
  26. Winawer S. J., St John J., Bond J., Hardcastle J. D., Kronborg O., Flehinger B., Schottenfeld D., Blinov N. N. Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68(4):505–513. [PMC free article] [PubMed] [Google Scholar]
  27. Winawer S. J., Zauber A. G., Ho M. N., O'Brien M. J., Gottlieb L. S., Sternberg S. S., Waye J. D., Schapiro M., Bond J. H., Panish J. F. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30;329(27):1977–1981. doi: 10.1056/NEJM199312303292701. [DOI] [PubMed] [Google Scholar]
  28. Winawer S. J., Zauber A. G., O'Brien M. J., Ho M. N., Gottlieb L., Sternberg S. S., Waye J. D., Bond J., Schapiro M., Stewart E. T. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993 Apr 1;328(13):901–906. doi: 10.1056/NEJM199304013281301. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES